Nicox granted expanded North American marketing rights for Sjö

Nicox S.A. has announced the acquisition of extended North American marketing rights for Sjö, an advanced diagnostic panel used for early detection of Sjögren’s syndrome.Under the agreement with Immco Diagnostics, Nicox will be the sole promotional entity of Sjö to health care practitioners in North America; however, Immco will carry out the test in its Clinical Laboratory Improvement Amendments-approved laboratory in Buffalo, NY. Immco will also be responsible for regulatory activities and reimbursement, according to a press release.

Full Story →